{"id":8545,"date":"2023-11-22T19:06:34","date_gmt":"2023-11-23T00:06:34","guid":{"rendered":"https:\/\/www.bluerocktx.com\/?p=8545"},"modified":"2024-01-23T13:12:05","modified_gmt":"2024-01-23T18:12:05","slug":"headlines-of-the-future-podcast-the-future-of-cell-and-gene-therapies","status":"publish","type":"post","link":"https:\/\/www.bluerocktx.com\/headlines-of-the-future-podcast-the-future-of-cell-and-gene-therapies\/","title":{"rendered":"Headlines of the Future Podcast: The Future of Cell and Gene Therapies"},"content":{"rendered":"<p>Parkinson\u2019s Disease is a relentless adversary for the human body, and over 10 million people worldwide fight a daily battle against it. Despite more than 65 years of research, current therapies sill only provide symptomatic relief.\u00a0Join us as our expert panel discusses why Parkinson\u2019s remains so hard to treat, and how cell and gene therapies could potentially offer a paradigm shift from current treatment options.<\/p>\n<p>In this episode of Headlines of the Future, host Piyal Bhoora is joined by Dr. Krystof Bankiewicz, Scientific Chair, Parkinson\u2019s and MSA at AskBio; Dr. Ahmed Enayetallah, Head of Development at Bluerock Therapeutics; and Dr. Patrick Bussfeld, Head of Medical Affairs, Cell &amp; Gene Therapies and Ophthalmology at Bayer.<\/p>\n<p><strong><a href=\"https:\/\/www.bayer.com\/en\/cell-and-gene-therapies-parkinsons\" target=\"_blank\" rel=\"noopener\">Click Here to Listen\u00a0<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Parkinson\u2019s Disease is a relentless adversary for the human body, and over 10 million people worldwide fight a daily battle against it. Despite more than 65 years of research, current therapies sill only provide symptomatic relief.\u00a0Join us as our expert panel discusses why Parkinson\u2019s [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":8805,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[59],"tags":[56,61,62,77,81],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Headlines of the Future Podcast: The Future of Cell and Gene Therapies - BlueRock Therapeutics LP<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.bluerocktx.com\/headlines-of-the-future-podcast-the-future-of-cell-and-gene-therapies\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Headlines of the Future Podcast: The Future of Cell and Gene Therapies - BlueRock Therapeutics LP\" \/>\n<meta property=\"og:description\" content=\"Parkinson\u2019s Disease is a relentless adversary for the human body, and over 10 million people worldwide fight a daily battle against it. Despite more than 65 years of research, current therapies sill only provide symptomatic relief.\u00a0Join us as our expert panel discusses why Parkinson\u2019s [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.bluerocktx.com\/headlines-of-the-future-podcast-the-future-of-cell-and-gene-therapies\/\" \/>\n<meta property=\"og:site_name\" content=\"BlueRock Therapeutics LP\" \/>\n<meta property=\"article:published_time\" content=\"2023-11-23T00:06:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-01-23T18:12:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.bluerocktx.com\/wp-content\/uploads\/2023\/11\/podcast_the-future-of-cell-and-gene.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"BlueRock Therapeutics\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"BlueRock Therapeutics\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.bluerocktx.com\/headlines-of-the-future-podcast-the-future-of-cell-and-gene-therapies\/\",\"url\":\"https:\/\/www.bluerocktx.com\/headlines-of-the-future-podcast-the-future-of-cell-and-gene-therapies\/\",\"name\":\"Headlines of the Future Podcast: The Future of Cell and Gene Therapies - BlueRock Therapeutics LP\",\"isPartOf\":{\"@id\":\"https:\/\/www.bluerocktx.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.bluerocktx.com\/headlines-of-the-future-podcast-the-future-of-cell-and-gene-therapies\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.bluerocktx.com\/headlines-of-the-future-podcast-the-future-of-cell-and-gene-therapies\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.bluerocktx.com\/wp-content\/uploads\/2023\/11\/podcast_the-future-of-cell-and-gene.jpg\",\"datePublished\":\"2023-11-23T00:06:34+00:00\",\"dateModified\":\"2024-01-23T18:12:05+00:00\",\"author\":{\"@id\":\"https:\/\/www.bluerocktx.com\/#\/schema\/person\/7bce67a9ee8dcf888329288a28761057\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.bluerocktx.com\/headlines-of-the-future-podcast-the-future-of-cell-and-gene-therapies\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.bluerocktx.com\/headlines-of-the-future-podcast-the-future-of-cell-and-gene-therapies\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.bluerocktx.com\/headlines-of-the-future-podcast-the-future-of-cell-and-gene-therapies\/#primaryimage\",\"url\":\"https:\/\/www.bluerocktx.com\/wp-content\/uploads\/2023\/11\/podcast_the-future-of-cell-and-gene.jpg\",\"contentUrl\":\"https:\/\/www.bluerocktx.com\/wp-content\/uploads\/2023\/11\/podcast_the-future-of-cell-and-gene.jpg\",\"width\":1080,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.bluerocktx.com\/headlines-of-the-future-podcast-the-future-of-cell-and-gene-therapies\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.bluerocktx.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Headlines of the Future Podcast: The Future of Cell and Gene Therapies\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.bluerocktx.com\/#website\",\"url\":\"https:\/\/www.bluerocktx.com\/\",\"name\":\"BlueRock Therapeutics LP\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.bluerocktx.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.bluerocktx.com\/#\/schema\/person\/7bce67a9ee8dcf888329288a28761057\",\"name\":\"BlueRock Therapeutics\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.bluerocktx.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/154b53ac9f1feafa6f14d0efa17a4fdb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/154b53ac9f1feafa6f14d0efa17a4fdb?s=96&d=mm&r=g\",\"caption\":\"BlueRock Therapeutics\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Headlines of the Future Podcast: The Future of Cell and Gene Therapies - BlueRock Therapeutics LP","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.bluerocktx.com\/headlines-of-the-future-podcast-the-future-of-cell-and-gene-therapies\/","og_locale":"en_US","og_type":"article","og_title":"Headlines of the Future Podcast: The Future of Cell and Gene Therapies - BlueRock Therapeutics LP","og_description":"Parkinson\u2019s Disease is a relentless adversary for the human body, and over 10 million people worldwide fight a daily battle against it. Despite more than 65 years of research, current therapies sill only provide symptomatic relief.\u00a0Join us as our expert panel discusses why Parkinson\u2019s [&hellip;]","og_url":"https:\/\/www.bluerocktx.com\/headlines-of-the-future-podcast-the-future-of-cell-and-gene-therapies\/","og_site_name":"BlueRock Therapeutics LP","article_published_time":"2023-11-23T00:06:34+00:00","article_modified_time":"2024-01-23T18:12:05+00:00","og_image":[{"width":1080,"height":1080,"url":"https:\/\/www.bluerocktx.com\/wp-content\/uploads\/2023\/11\/podcast_the-future-of-cell-and-gene.jpg","type":"image\/jpeg"}],"author":"BlueRock Therapeutics","twitter_card":"summary_large_image","twitter_misc":{"Written by":"BlueRock Therapeutics","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.bluerocktx.com\/headlines-of-the-future-podcast-the-future-of-cell-and-gene-therapies\/","url":"https:\/\/www.bluerocktx.com\/headlines-of-the-future-podcast-the-future-of-cell-and-gene-therapies\/","name":"Headlines of the Future Podcast: The Future of Cell and Gene Therapies - BlueRock Therapeutics LP","isPartOf":{"@id":"https:\/\/www.bluerocktx.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.bluerocktx.com\/headlines-of-the-future-podcast-the-future-of-cell-and-gene-therapies\/#primaryimage"},"image":{"@id":"https:\/\/www.bluerocktx.com\/headlines-of-the-future-podcast-the-future-of-cell-and-gene-therapies\/#primaryimage"},"thumbnailUrl":"https:\/\/www.bluerocktx.com\/wp-content\/uploads\/2023\/11\/podcast_the-future-of-cell-and-gene.jpg","datePublished":"2023-11-23T00:06:34+00:00","dateModified":"2024-01-23T18:12:05+00:00","author":{"@id":"https:\/\/www.bluerocktx.com\/#\/schema\/person\/7bce67a9ee8dcf888329288a28761057"},"breadcrumb":{"@id":"https:\/\/www.bluerocktx.com\/headlines-of-the-future-podcast-the-future-of-cell-and-gene-therapies\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.bluerocktx.com\/headlines-of-the-future-podcast-the-future-of-cell-and-gene-therapies\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.bluerocktx.com\/headlines-of-the-future-podcast-the-future-of-cell-and-gene-therapies\/#primaryimage","url":"https:\/\/www.bluerocktx.com\/wp-content\/uploads\/2023\/11\/podcast_the-future-of-cell-and-gene.jpg","contentUrl":"https:\/\/www.bluerocktx.com\/wp-content\/uploads\/2023\/11\/podcast_the-future-of-cell-and-gene.jpg","width":1080,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/www.bluerocktx.com\/headlines-of-the-future-podcast-the-future-of-cell-and-gene-therapies\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.bluerocktx.com\/"},{"@type":"ListItem","position":2,"name":"Headlines of the Future Podcast: The Future of Cell and Gene Therapies"}]},{"@type":"WebSite","@id":"https:\/\/www.bluerocktx.com\/#website","url":"https:\/\/www.bluerocktx.com\/","name":"BlueRock Therapeutics LP","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.bluerocktx.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.bluerocktx.com\/#\/schema\/person\/7bce67a9ee8dcf888329288a28761057","name":"BlueRock Therapeutics","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.bluerocktx.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/154b53ac9f1feafa6f14d0efa17a4fdb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/154b53ac9f1feafa6f14d0efa17a4fdb?s=96&d=mm&r=g","caption":"BlueRock Therapeutics"}}]}},"_links":{"self":[{"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/posts\/8545"}],"collection":[{"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/comments?post=8545"}],"version-history":[{"count":2,"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/posts\/8545\/revisions"}],"predecessor-version":[{"id":8559,"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/posts\/8545\/revisions\/8559"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/media\/8805"}],"wp:attachment":[{"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/media?parent=8545"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/categories?post=8545"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bluerocktx.com\/wp-json\/wp\/v2\/tags?post=8545"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}